Rachel Jones
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Rituximab and Belimumab Combination Therapy in PR3 Vasculitis (NCT03967925) | Rachel Jones | 2019-02-01 |
Track Rachel Jones automatically
Every clearance here is in the API, with alerts when new ones post.